FDAHealthApril 1, 2026
Wells Pharma of Houston LLC — fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
⚠️ cGMP deviations.
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- April 1, 2026
U.S. Nationwide.
What's affected?
- Product
- fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
- Lot code
- 020226202150202
Additional details
Lot 020226202150202, Exp Date 05/05/2026.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 50 syringes.
Get Health recall alerts
Delivered to your inbox. Free. No account required.